PUBLISHER: Orion Market Research | PRODUCT CODE: 1380434
PUBLISHER: Orion Market Research | PRODUCT CODE: 1380434
Title: Global Automated Microscopy Market Size, Share & Trends Analysis Report by Product (Inverted Microscope, Fluorescence Microscope, Electron Microscope, Scanning Electron Microscopes (SEM), Optical Microscope, and Others), by Application (Life Sciences and Biomedical Research, Semiconductors, and Others), and by End-User (Hospitals and Healthcare Facilities, Academic and Research Institutions, Clinical and Diagnostic Laboratories, and Others)Forecast Period (2023-2030).
The global automated microscopy market is anticipated to grow at a CAGR of 7.5% during the Forecast Period (2023-2030). The market's growth is attributed to the development in scanning electron microscope (SEM) technology. The development of automation features, including "Simple SEM" photography, montaging, and live elemental analysis, indicates that scanning electron microscopy technology constantly progressing. Users seeking more effective and convenient tools for their research and applications are attracted by the aforementioned enhancements. For instance, in January 2022, JEOL Introduced new Scanning Electron Microscope with "Simple SEM" Automation and Live Elemental And 3D Analysis. The new scanning electron microscope has productivity-enhancing automation, such as "Simple SEM" automated imaging, automated montaging (both image and EDS map),and live EDS analysis (spectrum and map).
The global automated microscopy market is segmented on the products, applications, and end-users. Based on the product, the market is sub-segmented into inverted microscope, fluorescence microscope, electron microscope, scanning electron microscopes, optical microscope, and others. Based on the applications, the market is sub-segmented into life sciences and biomedical research semiconductors, and others. Furthermore, based on end-user, the market is sub-segmented into hospitals and healthcare facilities, academic and research institutions, clinical and diagnostic laboratories, and others. Among the product, the optical microscope sub-category is expected to capture a significant portion of the market share. Optical microscopes are more accessible and cost-effective compared to other microscopy methods such as electron microscopy or scanning probe microscopy.
Among the end-user, the clinical and diagnostic laboratories sub-segment is expected to hold a considerable share of the global Automated Microscopy market. The segmental growth is attributed to growing demand for diagnostic and clinical laboratories. In order to help with disease diagnosis, patient treatment, and monitoring, clinical and diagnostic laboratories perform a variety of tests. The UNIQO 160 primarily addresses the needs of these labs with regard to the diagnosis of autoimmune diseases. For instance, in June 2023, Revvity Inc. launched the UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. The efficiency of the entire IIFT procedure that includes sample preparation, incubation, washing and mounting of slides, in addition to image acquisition and analysis is increased by the integrated solution.
The global automated microscopy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market globally, owing to the favorable economic environment and abundance of potential clients in the region. Further, number of significant automated microscopy businesses are expanding their operations, which is further anticipated to accelerate market expansion.
Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising tuberculosis (TB) diagnosis and treatment across the region. As a significant global health concern, TB requires prompt detection and treatment, that prompts for effective diagnostic techniques. The enhanced sensitivity and specificity of the μ-Scan 2.0 lead to improved control and management of tuberculosis. According to the National Institute of Health (NIH.gov), in May 2022, the μ-Scan 2.0 automation system was evaluated in a multi-center, double-blind trial involving 1726 smears. The accuracy of the system was 95.7%, the sensitivity was 87.7% (57/65), and the specificity was 96.0% (1,594/1,661). The negative predictive value was 97.8% at a prevalence of 8.2%. The μ-Scan 2.0 automation system was found to have higher TB smear sensitivity and laboratory efficiency than manual smear microscopy, and provides a cost effective solution for TB diagnosis and control. It can also be used remotely through an internet connection, making it suitable for areas with limited medical resources.
The major companies serving the global automated microscopy market include: Hitachi High-Tech Corp., Holmarc Opto-Mechatronics Ltd., JEOL Ltd., Keyence Corp., Leica Microsystems, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, HORIBA launched EasyImage, a new imaging tool for Raman microscopy. EasyImage is designed to help new users to quickly generate publication-ready results. It provides guidance on the 5 key steps for generating chemical images using Raman spectroscopy, focusing and selecting an area of interest, optimizing imaging parameters, selecting a spectral fingerprint, previewing measurements, and collecting a high-quality chemical image.